Fibroblast protein profile analysis highlights the role of oxidative stress and vitamin K recycling in the pathogenesis of pseudoxanthoma elasticum

Proteomics - Clinical Applications

Volumn 3, Issue 9, 2009, Pages 1084-1098

  Boraldi, Federica ^a   Annovi, Giulia ^a   Guerra, Deanna ^a   DeVincenzi, Chiara Paolinelli ^a   Garcia Fernandez, Maria Inmaculada ^b   Panico, Fulvio ^a   De Santis, Georgio ^a   Tiozzo, Roberta ^a   Ronchetti, Ivonne ^a   Quaglino, Daniela ^a  

^a UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

^b UNIVERSITY OF MÁLAGA   (Spain)

Author keywords

Ectopic calcification; Elastin; Fibroblast proteome; MRP6; PXE

Indexed keywords

CELL PROTEIN; FIBROBLAST PROTEIN; REACTIVE OXYGEN METABOLITE; UNCLASSIFIED DRUG;

ADULT; AMINO ACID SEQUENCE; ARTICLE; CELL CULTURE; CELL MEMBRANE; CONTROLLED STUDY; DNA METHYLATION; ELASTIC FIBER; HUMAN; HUMAN CELL; IN VITRO STUDY; LIPID PEROXIDATION; OXIDATIVE STRESS; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN STRUCTURE; PSEUDOXANTHOMA ELASTICUM; SKIN FIBROBLAST; VITAMIN K METABOLISM;

EID: 70350774544     PISSN: 18628346     EISSN: None     Source Type: Journal    
DOI: 10.1002/prca.200900007     Document Type: Article

References (71)

1. Neldner, K. H., Struk, B., in: Royce, P. M., Steinmann, B. (Eds.), Connective Tissue and its Heritable Disorders, Wiley, New York, 2002, pp. 561-583.
2. Gheduzzi, D., Sammarco, R., Quaglino, D., Bercovitch, L. et al., Extracutaneous ultrastructural alterations in pseudoxanthoma elasticum. Ultrastruct. Pathol. 2003, 27, 375-384.
3. Pasquali-Ronchetti, I., Volpin, D., Baccarani-Contri, M., Castellani, I., Peserico, A., Pseudoxanthoma elasticum. Biochemical and ultrastructural studies. Dermatologica 1981, 63, 307-325.
4. Homolya, L., Varadi, A., Sarkadi, B., Multidrug resistance-associated proteins: export pumps for conjugates with glutathione, glucuronate or sulphate. Biofactors 2003, 17, 103-114.
5. Matsuzaki, Y., Nakano, A., Jiang, Q. J., Pulkkinen, L., Uitto, J., Tissue-specific expression of the ABCC6 gene. J. Invest. Dermatol. 2005, 125, 900-905.
6. Quaglino, D., Boraldi, F., Barbieri, D., Croce, A. et al., Abnormal phenotype of in vitro dermal fibroblasts from patients with pseudoxanthoma elasticum (PXE). Biochim. Biophys. Acta 2000, 1501, 51-62.
7. Passi, A., Albertini, R., Baccarani-Contri, M., DeLuca, G. et al., Proteoglycan alterations in skin fibroblast cultures from patients affected with pseudoxanthoma elasticum. Cell. Biochem. Funct. 1996, 14, 111-120.
8. Quaglino, D., Sartor, L., Garbisa, S., Boraldi, F. et al., Dermal fibroblasts from pseudoxanthoma elasticum patients have raised MMP-2 degradative potential. Biochim. Biophys. Acta 2005, 1741, 42-47.
9. Boraldi, F., Quaglino, D., Croce, M. A., Garcia-Fernandez, M. I. et al., Multidrug resistance protein-6 (MRP6) in human dermal fibroblasts. Comparison between cells from normal subjects and from pseudoxanthoma elasticum patients. Matrix Biol. 2003, 22, 491-500.
10. Gheduzzi, D., Boraldi, F., Annovi, G., DeVincenzi-Paolinelli C. et al., Matrix Gla protein is involved in elastic fibre calcification in the dermis of pseudoxanthoma elasticum patients. Lab. Invest. 2007, 87, 998-1008.
11. Pasquali-Ronchetti, I., Garcia-Fernandez, M. I., Boraldi, F., Quaglino, D. et al., Oxidative stress in fibroblasts from patients with pseudoxanthoma elasticum: possible role in the pathogenesis of clinical manifestations. J. Pathol. 2006, 208, 54-61.
12. Garcia-Fernandez, M. I., Gheduzzi,D., Boraldi, F., DeVincenzi-Paolinelli, C. et al., Parameters of oxidative stress are present in the circulation of PXE patients. Biochim. Biophys. Acta 2008, 1782, 474-481.
13. Jiang, Q., Endo, M., Dibra, F., Wang, K., Uitto, J., Pseudoxanthoma elasticum is a metabolic disease. J. Invest. Dermatol. 2009, 129, 348-354.
14. Baccarani-Contri, M., Bacchelli, B., Boraldi, F., Quaglino, D. et al., Characterization of pseudoxanthoma elasticum-like lesions in the skin of patients with beta-thalassemia. J. Am. Acad. Dermatol. 2001, 44, 33-39.
15. Hamlin, N., Beck, K., Bacchelli, B., Cianciulli, P. et al., Acquired pseudoxanthoma elasticum-like syndrome in beta-thalassaemia patients. Br. J. Haematol. 2003, 122, 852-854.
16. Gheduzzi, D., Guidetti, R., Anzivino, C., Tarugi, P. et al., ABCC6 mutations in Italian families affected by pseudoxanthoma elasticum (PXE). Hum. Mutat. 2004, 24, 438-439.
17. Bussolino, F., Camussi, G., Aglietta, M., Braquet, P. et al., Human endothelial cells are target for platelet-activating factor. I. Platelet-activating factor induces changes in cytoskeleton structures. J. Immunol. 1987, 139, 2439-2446.
18. Luo, J., Li, N., Robinson, J. P., Shi, R., Detection of reactive oxygen species by flow cytometry after spinal cord injury. J. Neurosci. Methods 2002, 120, 105-112.
19. Boya, P., De-La-Peña, A., Beloqui, O., Larrea, E. et al., Antioxidant status and glutathione metabolism in peripheral blood mononuclear cells from patients with chronic hepatitis C. J. Hepatol. 1999, 31, 808-814.
20. Marklund, S. L., Extracellular superoxide dismutase. Methods Enzymol. 2002, 349, 74-80.
21. Levine, R. L., Garland, D., Oliver, C. N., Amici, A. et al., Determination of carbonyl content in oxidatively modified proteins. Methods Enzymol. 1990, 186, 464-478.
22. Clark, S. J., Harrison, J., Paul, C. L., Frommer, M., High sensitivity mapping of methylated cytosines. Nucleic Acids Res. 1994, 22, 2990-2997.
23. Boraldi, F., Annovi, G., DeVincenzi-Paolinelli, C., Tiozzo, R., Quaglino, D., The effect of serum withdrawal on the protein profile of quiescent human dermal fibroblasts in primary cell culture. Proteomics 2008, 8, 66-82.
24. Bradford, M. M., A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 1976, 72, 248-254.
25. Honore, B., Vorum, H., Pedersen, A. E., Buus, S., Claesson, M. H., Changes in protein expression in p53 deleted spontaneous thymic lymphomas. Exp. Cell Res. 2004, 295, 91-101.
26. Boraldi, F., Annovi, G., Carraro, F., Naldini, A. et al., Hypoxia influences the cellular cross-talk of human dermal fibroblasts. A proteomic approach. Biochim. Biophys. Acta 2007, 1774, 1402-1413.
27. LeSaux, O., Urban, Z., Tschuch, C., Csiszar, K. et al., Mutations in a gene encoding an ABC transporter cause pseudoxanthoma elasticum. Nat. Genet. 2000, 25, 223-227.
28. Bergen, A. A., Plomp, A. S., Schuurman, E. J., Terry, S. et al., Mutations in ABCC6 cause pseudoxanthoma elasticum. Nat. Genet. 2000, 25, 228-231.
29. Ringpfeil, F., Lebwohl, M. G., Christiano, A. M., Uitto, J., Pseudoxanthoma elasticum: mutations in the MRP6 gene encoding a transmembrane ATP-binding cassette (ABC) transporter. Proc. Natl. Acad. Sci. USA 2000, 97, 6001-6006.
30. Jezek, P., Hlavatá, L., Mitochondria in homeostasis of reactive oxygen species in cell, tissues, and organism. Int. J. Biochem. Cell Biol. 2005, 37, 2478-2503.
31. Stephens, J. W., Khanolkar, M. P., Bain, S. C., The biological relevance and measurement of plasma markers of oxidative stress in diabetes and cardiovascular disease. Atherosclerosis 2009, 202, 321-329.
32. Bickers, D. R., Athar, M., Oxidative stress in the pathogenesis of skin disease. J. Invest. Dermatol. 2006, 126, 2565-2575.
33. Hitchler, M. J., Domann, F. E., An epigenetic perspective on the free radical theory of development. Free Radic. Biol. Med. 2007, 43, 1023-1036.
34. Cappello, F., DeMacario, E. C., Marasà, L., Zummo, G., Macario, A. J., Hsp60 expression, new locations, functions and perspectives for cancer diagnosis and therapy. Cancer Biol. Ther. 2008, 7, 801-809.
35. Chen, H. S., Shan, Y. X., Yang, T. L., Lin, H. D. et al., Insulin deficiency downregulated heat shock protein 60 and IGF-1 receptor signaling in diabetic myocardium. Diabetes 2005, 54, 175-181.
36. Dalle-Donne, I., Rossi, R., Milzani, A., DiSimplicio, P., Colombo, R., The actin cytoskeleton response to oxidants: from small heat shock protein phosphorylation to changes in the redox state of actin itself. Free Radic. Biol. Med. 2001, 31, 1624-1632.
37. D'Addario, M., Arora, P. D., Ellen, R. P., McCulloch, C. A., Regulation of tension-induced mechanotranscriptional signals by the microtubule network in fibroblasts. J. Biol. Chem. 2003, 278, 53090-53097.
38. Stadtman, E. R., Levine, R. L., Protein oxidation. Ann. NY Acad. Sci. USA 2000, 899, 191-208.
39. Jacob, R. F., Mason, R. P., Lipid peroxidation induces cholesterol domain formation in model membranes. J. Biol. Chem. 2005, 280, 39380-39387.
40. McLean, L. R., Hagaman, K. A., Effect of lipid physical state on the rate of peroxidation of liposomes. Free Radic. Biol. Med. 1992, 12, 113-119.
41. Liang, X., Huang, Y., Physical state changes of membrane lipids in human lung adenocarcinoma A(549) cells and their resistance to cisplatin. Int. J. Biochem. Cell. Biol. 2002, 34, 1248-1255.
42. Chasserot-Golaz, S., Vitale, N., Umbrecht-Jenck, E., Knight, D. et al., Annexin 2 promotes the formation of lipid microdomains required for calcium-regulated exocytosis of densecore vesicles. Mol. Biol. Cell. 2005, 16, 1108-1119.
43. Molero, L., García-Méndez, A., Alonso-Orgaz, S., Carrasco, C. et al., Proteomic approach to identify changes in protein expression modified by 17beta-oestradiol in bovine vascular smooth muscle cells. Clin. Sci. (Lond) 2005, 109, 457-463.
44. Caplan, J. F., Filipenko, N. R., Fitzpatrick, S. L.,Waisman, D.M., Regulation of annexin A2 by reversible glutathionylation. J. Biol. Chem. 2004, 279, 7740-7750.
45. Nordberg, J., Arnér, E. S., Reactive oxygen species, antioxidants, and the mammalian thioredoxin system. Free Radic. Biol. Med. 2001, 31, 1287-1312.
46. Mazzocco, M., Maffei, M., Egeo, A., Vergano, A. et al., The identification of a novel human homologue of the SH3 binding glutamic acid-rich (SH3BGR) gene establishes a new family of highly conserved small proteins related to thioredoxin superfamily. Gene 2002, 291, 233-239.
47. Masoro, E. J., Caloric restriction and aging: an update. Exp. Gerontol. 2000, 35, 299-305.
48. Wang, H., Schultz, R., Hong, J., Cundiff, D. L. et al., Cell surface-dependent generation of angiostatin4.5. Cancer Res. 2004, 64, 162-168.
49. Sriburi, R., Bommiasamy, H., Buldak, G. L., Robbins, G. R. et al., Coordinate regulation of phospholipid biosynthesis and secretory pathway gene expression in XBP-1(S)-induced endoplasmic reticulum biogenesis. J. Biol. Chem. 2007, 282, 7024-7034.
50. Gold, L. I., Rahman, M., Blechman, K. M., Greives, M. R. et al., Overview of the role for calreticulin in the enhancement of wound healing through multiple biological effects. J. Invest. Dermatol. Symp. Proc. 2006, 11, 57-65.
51. Coppolino, M. G., Woodside, M. J., Demaurex, N., Grinstein, S. et al., Calreticulin is essential for integrin-mediated calcium signalling and cell adhesion. Nature 1997, 386, 843-847.
52. Wu, M., Massaeli, H., Durston, M., Mesaeli, N., Differential expression and activity of matrix metalloproteinase-2 and -9 in the calreticulin deficient cells. Matrix Biol. 2007, 26, 463-472.
53. Chen, E., Proestou, G., Bourbeau, D., Wang, E., Rapid up-regulation of peptide elongation factor EF-1alpha protein levels is an immediate early event during oxidative stress-induced apoptosis. Exp. Cell Res. 2000, 259, 140-148.
54. Sitia, R., Molteni, S. N., Stress, protein (mis)folding, and signaling: the redox connection. Sci. STKE 2004, 239, pe27.
55. Nuss, J. E., Choksi, K. B., DeFord, J. H., Papaconstantinou, J., Decreased enzyme activities of chaperones PDI and BiP in aged mouse livers. Biochem. Biophys. Res. Commun. 2008, 365, 355-361.
56. Wajih, N., Hutson, S. M., Wallin, R., Disulfide-dependent protein folding is linked to operation of the vitamin K cycle in the endoplasmic reticulum. A protein disulfide isomerase-VKORC1 redox enzyme complex appears to be responsible for vitamin K1 2,3-epoxide reduction. J. Biol. Chem. 2007, 282, 2626-2635.
57. Wajih, N., Sane, D. C., Hutson, S. M., Wallin, R., The inhibitory effect of calumenin on the vitamin K-dependent gamma-carboxylation system. Characterization of the system in normal and warfarin-resistant rats. J. Biol. Chem. 2004, 279, 25276-25283.
58. Schurgers, L. J., Teunissen, K. J., Knapen, M. H., Geusens, P. et al., Characteristics and performance of an immunosorbent assay for human matrix Gla-protein. Clin. Chim. Acta 2005, 351, 131-138.
59. Vorum, H., Jacobsen, C., Honoré, B., Calumenin interacts with serum amyloid P component. FEBS Lett. 2000, 465, 129-134.
60. Baccarani-Contri, M., Vincenzi, D., Cicchetti, P., Mori, G., Pasquali-Ronchetti, I., Immunochemical identification of abnormal costituent in the dermis of pseudoxanthoma elasticum patients. Eur. J. Histochem. 1994, 38, 111-123.
61. LeSaux, O., Bunda, S., VanWart, C. M., Douet, V. et al., Serum factors from pseudoxanthoma elasticum patients alter elastic fibre formation in vitro. J. Invest. Dermatol. 2006, 126, 1497-1505.
62. Baccarani-Contri, M., Boraldi, F., Taparelli, F., DePaepe, A., Pasquali-Ronchetti, I., Matrix proteins with high affinity for calcium ions are associated with mineralization within the elastic fibres of pseudoxanthoma elasticum dermis. Am. J. Pathol. 1996, 148, 569-577.
63. Schulz-Knappe, P., Schrader, M., Zucht, H. D., The peptidomics concept. Comb. Chem. High Throughput Screen 2005, 8, 697-704.
64. Piehler, A. P., Hellum, M., Wenzel, J. J., Kaminski, E. et al., The human ABC transporter pseudogene family: evidence for transcription and gene-pseudogene interference. BMC Genomics 2008, 9, 165.
65. Borst, P., VanDeWetering, K., Schlingemann, R., Does the absence of ABCC6 (multidrug resistance protein 6) in patients with pseudoxanthoma elasticum prevent the liver from providing sufficient vitamin K to the periphery? Cell Cycle 2008, 7, 1575-1579.
66. Zarbock, R., Hendig, D., Szliska, C., Kleesiek, K., Götting, C., Pseudoxanthoma elasticum: genetic variations in antioxidant genes are risk factors for early disease onset. Clin. Chem. 2007, 53, 1734-1740.
67. Green, J. A., Yamada, K. M., Three-dimensional micro-environments modulate fibroblast signaling responses. Adv. Drug Deliv. Rev. 2007, 59, 1293-1298.
68. Bacchelli, B., Quaglino, D., Gheduzzi, D., Taparelli, F. et al., Identification of heterozygote carriers in families with a recessive form of pseudoxanthoma elasticum (PXE). Mod. Pathol. 1999, 12, 1112-1123.
69. Martin, L., Maitre, F., Bonicel, P., Daudon, P. et al., Heterozygosity for a single mutation in the ABCC6 gene may closely mimic PXE: consequences of this phenotype overlap for the definition of PXE. Arch. Dermatol. 2008, 144, 301-306.
70. Li, Q., Grange, D. K., Armstrong, N. L., Whelan, A. J. et al., Mutations in the GGCX and ABCC6 genes in a family with pseudoxanthoma elasticum-like phenotypes. J. Invest. Dermatol. 2009, 129, 553-563.
71. Vanakker, O. M., Martin, L., Gheduzzi, D., Leroy, B. P. et al., Pseudoxanthoma elasticum-like phenotype with cutis laxa and multiple coagulation factor deficiency represents a separate genetic entity. J. Invest. Dermatol. 2007, 127, 581-587.